116 related articles for article (PubMed ID: 9012544)
1. Effect of Z-100, an immunomodulator extracted from human type tubercle bacilli, on the pulmonary metastases of Lewis lung carcinoma in attempt to regulate suppressor T cells and suppressor factor, IL-4.
Emori Y; Sasaki H; Hayashi Y; Nomoto K
Biotherapy; 1996; 9(4):249-56. PubMed ID: 9012544
[TBL] [Abstract][Full Text] [Related]
2. Z-100, a polysaccharide-rich preparation extracted from the human type Mycobacterium tuberculosis, improves the resistance of Meth-A tumor-bearing mice to endogenous septic infection.
Sasaki H; Kobayashi M; Emori Y; Ohya O; Hayashi Y; Nomoto K
Biotherapy; 1997; 10(2):139-43. PubMed ID: 9373736
[TBL] [Abstract][Full Text] [Related]
3. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
Sredni B; Tichler T; Shani A; Catane R; Kaufman B; Strassmann G; Albeck M; Kalechman Y
J Natl Cancer Inst; 1996 Sep; 88(18):1276-84. PubMed ID: 8797767
[TBL] [Abstract][Full Text] [Related]
4. Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.
Gold JE; Osband ME
Clin Immunol Immunopathol; 1994 Jun; 71(3):325-32. PubMed ID: 7911078
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis.
Sasaki H; Schmitt DA; Kobayashi M; Hayashi Y; Pollard RB; Suzuki F
Nat Immun; 1993; 12(3):152-64. PubMed ID: 8329838
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.
Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC
Blood; 1997 Apr; 89(7):2529-36. PubMed ID: 9116299
[TBL] [Abstract][Full Text] [Related]
7. The effect of combination therapy of radiation and Z-100, an arabinomannan on tumor growth in mice.
Hayashi Y; Sasaki H; Emori Y; Nomoto K
Biotherapy; 1993; 7(1):63-9. PubMed ID: 8068485
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis.
Oka H; Emori Y; Sasaki H; Shiraishi Y; Yoshinaga K; Kurimoto T
Microbiol Immunol; 2002; 46(5):343-51. PubMed ID: 12139394
[TBL] [Abstract][Full Text] [Related]
9. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
10. Etoposide induction of tumor immunity in Lewis lung cancer.
Slater LM; Stupecky M; Sweet P; Osann K; Eklof A; Arquilla ER
Cancer Chemother Pharmacol; 2001 Oct; 48(4):327-32. PubMed ID: 11710634
[TBL] [Abstract][Full Text] [Related]
11. Z-100, a lipid-arabinomannan extracted from Mycobacterium tuberculosis, improves the resistance of thermally injured mice to herpes virus infections.
Kobayashi M; Herndon DN; Pollard RB; Suzuki F
Immunol Lett; 1994 Jun; 40(3):199-205. PubMed ID: 7959887
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis.
Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
Cancer Res; 1990 Jul; 50(13):4032-7. PubMed ID: 2354453
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12.
Oka H; Shiraishi Y; Sasaki H; Yoshinaga K; Emori Y; Takei M
Biol Pharm Bull; 2003 Sep; 26(9):1336-41. PubMed ID: 12951482
[TBL] [Abstract][Full Text] [Related]
14. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
15. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
[TBL] [Abstract][Full Text] [Related]
17. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
Pollard RB; Schmitt DA; Sasaki H; Hayashi Y; Suzuki F
Anticancer Res; 1990; 10(2A):285-90. PubMed ID: 2346302
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma.
Kobayashi M; Pollard RB; Suzuki F
Anticancer Drugs; 1997 Feb; 8(2):156-63. PubMed ID: 9073311
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor effect of cepharanthin--mechanism of the antimetastatic effect on Lewis lung carcinoma (3LL)].
Ono M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):249-55. PubMed ID: 3341787
[TBL] [Abstract][Full Text] [Related]
20. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
